48
When asked why he founded Unnatural Products (UNP), a developer of oral macrocyclic peptide therapeutics, Cameron Pye, PhD, attributes the decision at least in part to “being in the right place at the right time.” Pye and his co-founder Joshua Schwochert, PhD, met as doctoral students in the laboratory of Scott Lokey, PhD, at the University of California, Santa Cruz. Their research there exposed them to pre-competitive collaborations with pharmaceutical companies interested in macroyclic peptides.
Research in the Lokey lab…